Novel series of substituted biphenylmethyl urea derivatives as MCH-R1 antagonists for the treatment of obesity

Silvia Galiano, Javier Ceras, Nuria Cirauqui, Silvia Pérez, Laura Juanenea, Gildardo Rivera, Ignacio Aldana, Antonio Monge

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

We have designed and synthesized two novel series of MCH-R1 antagonists based on a substituted biphenylmethyl urea core. SAR was explored, suggesting that optimal binding with the receptor was achieved when the biphenylmethyl group and the linker were substituted on the same nitrogen of the urea moiety. Compound 1-(3′-cyano-4-biphenylmethyl)-3-(2-hydroxy-1,1-dimethylethyl)-1-{2-[1-(4-methylbenzyl)-4-piperidinyl]ethyl}urea 2t showed the best antagonist binding activity to the MCH-R1 with a 43 nM Ki.

Original languageEnglish
Pages (from-to)3896-3911
Number of pages16
JournalBioorganic and Medicinal Chemistry
Volume15
Issue number11
DOIs
StatePublished - 1 Jun 2007
Externally publishedYes

Keywords

  • Biphenylmethyl urea
  • MCH
  • MCH-R1 antagonist
  • Obesity

Fingerprint

Dive into the research topics of 'Novel series of substituted biphenylmethyl urea derivatives as MCH-R1 antagonists for the treatment of obesity'. Together they form a unique fingerprint.

Cite this